Quarterly report pursuant to Section 13 or 15(d)

License and Transfer Agreement - Additional Information (Detail)

v3.7.0.1
License and Transfer Agreement - Additional Information (Detail) - License and Transfer Agreement [Member] - Enumeral Biomedical Holdings Inc [Member] - USD ($)
 3 Months Ended 6 Months Ended
Apr. 18, 2016
Jun. 30, 2017
Jun. 30, 2017
Contingencies And Commitments [Line Items]      
Upfront license fee payment $ 250,000    
Maintenance fee payment 750,000    
Research and Development [Member]      
Contingencies And Commitments [Line Items]      
Upfront fees $ 1,000,000 $ 0 $ 0